Pharmacokinetic Studies of Antifolate Drug CB3988 Using NMR Spectroscopy
Author Information
Author(s): D.R. Newell, R.J. Maxwell, G.M.F. Bisset, D.I. Jodrell, J.R. Griffiths
Primary Institution: Institute of Cancer Research
Hypothesis
The study aims to evaluate the pharmacokinetics of the antifolate drug CB3988 using non-invasive '9F-NMR spectroscopy.
Conclusion
CB3988 is rapidly cleared from the body through biliary and urinary excretion, and '9F-NMR spectroscopy is a useful method for studying its pharmacokinetics.
Supporting Evidence
- CB3988 was detected in both the gall bladder and urinary bladder after administration.
- NMR signal from the upper abdomen peaked at 10-40 minutes post-administration.
- Comparison with HPLC showed similar results for drug concentrations in bile and urine.
- CB3988 was cleared rapidly from the body, contrasting with the nephrotoxic drug CB3717.
Takeaway
Scientists used a special technique to see how a new cancer drug moves through mice and rats, and they found it leaves the body quickly.
Methodology
The study used '9F-NMR spectroscopy to track the drug's movement in mice and rats after intravenous administration.
Limitations
The sensitivity of NMR is limited, which may restrict its application to drugs that can be administered in larger doses.
Participant Demographics
Male C57BL x DBA2 Fl hybrid mice and female Wistar rats were used.
Statistical Information
P-Value
0.004
Statistical Significance
p=0.004
Want to read the original?
Access the complete publication on the publisher's website